Status:

COMPLETED

Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients

Lead Sponsor:

Novartis Pharmaceuticals

Conditions:

Acromegaly

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic patients.

Eligibility Criteria

Inclusion

  • Patients with active acromegaly due to a pituitary adenoma
  • Patients who have been previously treated for acromegaly with certain medications may be required to be without certain medications prior to entering the study

Exclusion

  • Patients with compression of the optic chiasm causing any visual field defect
  • Patients who require a surgical intervention for relief of any sign or symptom associated with tumor compression
  • Patients who have received radiotherapy in the 2 years prior to the start of the trial
  • Patients who have congestive heart failure, unstable angina, cardia arrhythmia, or a history of acute myocardial infarction within the three months preceding enrollment
  • Patients with gallstone disease
  • Patients with chronic liver disease
  • Known hypersensitivity to Sandostatin or Sandostatin LAR
  • Female patients who are pregnant or lactating, or are of childbearing potential and not practicing a medically acceptable method of birth control and highly effective method for birth control
  • History of immunocompromise, including a positive HIV test result
  • Patients who have a history of alcohol or drug abuse in the six-month period prior to the enrollment visit
  • Patients who have participated in any clinical investigation with an investigational drug within 4 weeks prior to dosing

Key Trial Info

Start Date :

March 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT00088582

Start Date

March 1 2004

Last Update

November 7 2016

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Cedars Sinai Medical Center

Los Angeles, California, United States, 90048

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

3

University of Michigan Medical Center

Ann Arbor, Michigan, United States, 48108

4

New York University/VA Medical Center

New York, New York, United States, 10010